These two independent studies showed increased tumor burdens and shortened colon lengths in Aim2−/− mice compared to wild-type mice, while the inflammasome-dependent cytokines IL-1β and IL-18 were intact in the Aim2−/− colon, indicating that AIM2 plays an inflammasome-independent role in the development of colon cancer. This evidence concerns the gene AIM2 and neoplasm.